Insider Trading disclosures for Capricor Therapeutics Inc

The latest disclosure was made by Linda Marban in Capricor Therapeutics Inc where a trade of 25,000 Stock Option (Right to Buy) done was reported to US exchanges on March 3, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Linda Marban	Director, CHIEF EXECUTIVE OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	03 Mar 2025	25,000	0	-		-	Stock Option (Right to Buy)
Linda Marban	Director, CHIEF EXECUTIVE OFFICER	Other type of transaction at price $ 0.00 per share.	03 Mar 2025	12,500	211,104 (4%)	0%		0	Common Stock
Linda Marban	Director, CHIEF EXECUTIVE OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.39 per share.	03 Mar 2025	25,000	223,604 (4%)	0%	1.4	34,750	Common Stock
Anthony J. Bergmann	CHIEF FINANCIAL OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.39 per share.	03 Mar 2025	2,500	8,223 (0%)	0%	1.4	3,475	Common Stock
Anthony J. Bergmann	CHIEF FINANCIAL OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	03 Mar 2025	2,500	0	-		-	Stock Option (Right to Buy)
George W. Dunbar	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.39 per share.	03 Mar 2025	750	11,306 (0%)	0%	1.4	1,043	Common Stock
George W. Dunbar	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	03 Mar 2025	750	0	-		-	Stock Option (Right to Buy)
Frank Litvack	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	03 Mar 2025	25,000	0	-		-	Stock Option (Right to Buy)
Frank Litvack	Director	Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.67 per share.	03 Mar 2025	2,543	129,839 (2%)	0%	13.7	34,763	Common Stock
Frank Litvack	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.39 per share.	03 Mar 2025	25,000	132,382 (2%)	0%	1.4	34,750	Common Stock
Earl M. Collier	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.39 per share.	27 Feb 2025	750	57,606 (1%)	0%	1.4	1,043	Common Stock
Earl M. Collier	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	27 Feb 2025	750	0	-		-	Stock Option (Right to Buy)
Michael Kelliher	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2025	11,940	11,940	-		-	Stock Option (Right to Buy)
Michael Kelliher	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2025	5,750	5,750	-		-	Stock Option (Right to Buy)
Michael Kelliher	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2025	1,440	1,440	-		-	Stock Option (Right to Buy)
Philip J. Gotwals	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2025	11,940	11,940	-		-	Stock Option (Right to Buy)
Paul Gisbert Auwaerter	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2025	11,940	11,940	-		-	Stock Option (Right to Buy)
Paul Gisbert Auwaerter	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2025	1,440	1,440	-		-	Stock Option (Right to Buy)
Paul Gisbert Auwaerter	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2025	5,750	5,750	-		-	Stock Option (Right to Buy)
Karimah Es Sabar	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2025	11,940	11,940	-		-	Stock Option (Right to Buy)
Karimah Es Sabar	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2025	2,520	2,520	-		-	Stock Option (Right to Buy)
Karimah Es Sabar	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2025	5,750	5,750	-		-	Stock Option (Right to Buy)
Karen G. Krasney	EVP, GENERAL COUNSEL	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2025	60,000	60,000	-		-	Stock Option (Right to Buy)
Anthony J. Bergmann	CHIEF FINANCIAL OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2025	3,342	5,723 (0%)	0%		0	Common Stock
Anthony J. Bergmann	CHIEF FINANCIAL OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2025	75,000	75,000	-		-	Stock Option (Right to Buy)
Anthony J. Bergmann	CHIEF FINANCIAL OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2025	6,170	6,170	-		-	Stock Option (Right to Buy)
Linda Marban	Director, CHIEF EXECUTIVE OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2025	34,962	34,962	-		-	Stock Option (Right to Buy)
Linda Marban	Director, CHIEF EXECUTIVE OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2025	210,000	210,000	-		-	Stock Option (Right to Buy)
Philip J. Gotwals	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2025	2,160	2,160	-		-	Stock Option (Right to Buy)
David B. Musket	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2025	5,750	5,750	-		-	Stock Option (Right to Buy)
David B. Musket	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2025	6,480	6,480	-		-	Stock Option (Right to Buy)
David B. Musket	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2025	11,940	11,940	-		-	Stock Option (Right to Buy)
Earl M. Collier	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2025	11,940	11,940	-		-	Stock Option (Right to Buy)
Earl M. Collier	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2025	5,750	5,750	-		-	Stock Option (Right to Buy)
Earl M. Collier	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2025	3,240	3,240	-		-	Stock Option (Right to Buy)
Frank Litvack	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2025	50,000	50,000	-		-	Stock Option (Right to Buy)
George W. Dunbar	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2025	11,940	11,940	-		-	Stock Option (Right to Buy)
George W. Dunbar	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2025	3,600	3,600	-		-	Stock Option (Right to Buy)
George W. Dunbar	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2025	5,750	5,750	-		-	Stock Option (Right to Buy)
Philip J. Gotwals	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2025	5,750	5,750	-		-	Stock Option (Right to Buy)
Karen G. Krasney	EVP, GENERAL COUNSEL	Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.39 per share.	13 Dec 2024	8,000	28,047 (0%)	0%	1.4	11,120	Common Stock
Karen G. Krasney	EVP, GENERAL COUNSEL	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	13 Dec 2024	3,000	0	-		-	Stock Option (Right to Buy)
Karen G. Krasney	EVP, GENERAL COUNSEL	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	13 Dec 2024	5,000	0	-		-	Stock Option (Right to Buy)
Frank Litvack	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.10 per share.	02 Dec 2024	20,391	46,278 (0%)	0%	1.1	22,430	Common Stock
Frank Litvack	Director	Gift of securities by or to the insider at price $ 0.00 per share.	02 Dec 2024	20,391	0	-		-	Warrants (Right to Buy)
Frank Litvack	Director	Gift of securities by or to the insider at price $ 0.00 per share.	02 Dec 2024	20,391	20,391	-		-	Warrants (Right to Buy)
Frank Litvack	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	02 Dec 2024	20,391	0	-		-	Warrants (Right to Buy)
David B. Musket	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.39 per share.	07 Aug 2024	34,000	81,692 (1%)	0%	1.4	47,260	Common Stock
David B. Musket	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	07 Aug 2024	34,000	75,000	-		-	Stock Option (Right to Buy)
David B. Musket	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Apr 2024	3,000	0	-		-	Stock Option (Right to Buy)
David B. Musket	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.39 per share.	23 Apr 2024	16,156	47,692 (0%)	0%	1.4	22,457	Common Stock
David B. Musket	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Apr 2024	1,050	0	-		-	Stock Option (Right to Buy)
David B. Musket	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Apr 2024	2,750	0	-		-	Stock Option (Right to Buy)
David B. Musket	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Apr 2024	5,750	0	-		-	Stock Option (Right to Buy)
David B. Musket	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Apr 2024	856	0	-		-	Stock Option (Right to Buy)
David B. Musket	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Apr 2024	2,750	0	-		-	Stock Option (Right to Buy)
Earl M. Collier	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.39 per share.	23 Apr 2024	30,000	56,856 (1%)	0%	1.4	41,700	Common Stock
Earl M. Collier	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Apr 2024	30,000	53,000	-		-	Stock Option (Right to Buy)
David Musket B.	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	15,170	15,170	-		-	Stock Option (Right to Buy)
W. Dunbar George	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	14,280	14,280	-		-	Stock Option (Right to Buy)
Karen Krasney G.	EVP, GENERAL COUNSEL	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	80,000	80,000	-		-	Stock Option (Right to Buy)
Philip Gotwals	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	29,250	29,250	-		-	Stock Option (Right to Buy)
W. George Dunbar	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	8,920	8,920	-		-	Stock Option (Right to Buy)
Gisbert Auwaerter Paul	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	890	890	-		-	Stock Option (Right to Buy)
Karimah Es Sabar	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	29,250	29,250	-		-	Stock Option (Right to Buy)
G. Krasney Karen	EVP, GENERAL COUNSEL	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	7,140	7,140	-		-	Stock Option (Right to Buy)
Linda Marban	Director, CHIEF EXECUTIVE OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	9,633	9,633	-		-	Stock Option (Right to Buy)
Michael Kelliher	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	4,730	4,730	-		-	Stock Option (Right to Buy)
Philip Gotwals	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	1,330	1,330	-		-	Stock Option (Right to Buy)
Es Sabar Karimah	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	4,460	4,460	-		-	Stock Option (Right to Buy)
Gisbert Paul Auwaerter	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	29,250	29,250	-		-	Stock Option (Right to Buy)
Michael Kelliher	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	890	890	-		-	Stock Option (Right to Buy)
J. Anthony Bergmann	CHIEF FINANCIAL OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	9,692	9,692	-		-	Stock Option (Right to Buy)
Es Sabar Karimah	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	14,280	14,280	-		-	Stock Option (Right to Buy)
Musket B. David	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	29,250	29,250	-		-	Stock Option (Right to Buy)
M. Collier Earl	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	14,280	14,280	-		-	Stock Option (Right to Buy)
Litvack Frank	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	200,000	200,000	-		-	Stock Option (Right to Buy)
Bergmann J. Anthony	CHIEF FINANCIAL OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	85,000	85,000	-		-	Stock Option (Right to Buy)
Collier Earl M.	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	8,030	8,030	-		-	Stock Option (Right to Buy)
Auwaerter Gisbert Paul	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	6,760	6,760	-		-	Stock Option (Right to Buy)
Gotwals Philip	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	6,370	6,370	-		-	Stock Option (Right to Buy)
Musket David B.	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	14,280	14,280	-		-	Stock Option (Right to Buy)
Marban Linda	Director, CHIEF EXECUTIVE OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	250,000	250,000	-		-	Stock Option (Right to Buy)
Kelliher Michael	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	29,250	29,250	-		-	Stock Option (Right to Buy)
Collier Earl M.	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	29,250	29,250	-		-	Stock Option (Right to Buy)
Michael Kelliher	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	30,000	30,000	-		-	Stock Option (Right to Buy)
Dunbar George W.	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	29,250	29,250	-		-	Stock Option (Right to Buy)
Frank Litvack	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	14 Aug 2023	20,748	0	-		-	Stock Option (Right to Buy)
Frank Litvack	Director	Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.61 per share.	14 Aug 2023	4,364	133,269 (2%)	0%	6.6	28,846	Common Stock
Frank Litvack	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.39 per share.	14 Aug 2023	20,748	137,633 (2%)	0%	1.4	28,840	Common Stock
Philip Gotwals	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jul 2023	115,000	115,000	-		-	Stock Option (Right to Buy)
Paul Gisbert Auwaerter	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Jul 2023	115,000	115,000	-		-	Stock Option (Right to Buy)
Linda Marban	Director, CHIEF EXECUTIVE OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.39 per share.	12 May 2023	20,749	198,604 (4%)	0%	1.4	28,841	Common Stock
Linda Marban	Director, CHIEF EXECUTIVE OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	12 May 2023	41,497	0	-		-	Stock Option (Right to Buy)
Xavier Avat	Former CBO	Sale of securities on an exchange or to another person at price $ 64258.00 per share.	17 Apr 2023	14,772	0 (0%)	0%	64258	949,219,176	Common Stock
Xavier Avat	FORMER CHIEF BUSINESS OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.46 per share.	28 Mar 2023	84,791	84,791 (1%)	1%	3.5	293,377	Common Stock
Xavier Avat	FORMER CHIEF BUSINESS OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Mar 2023	84,791	0	-		-	Stock Option (Right to Buy)
Xavier Avat	FORMER CHIEF BUSINESS OFFICER	Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.19 per share.	28 Mar 2023	70,019	14,772 (0%)	1%	4.2	293,380	Common Stock
Xavier Avat	FORMER CHIEF BUSINESS OFFICER	Sale of securities on an exchange or to another person at price $ 4.06 per share.	28 Mar 2023	3,000	0 (0%)	0%	4.1	12,180	Common Stock
Frank Litvack	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.39 per share.	21 Feb 2023	14,027	141,800 (2%)	0%	1.4	19,498	Common Stock
Frank Litvack	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	21 Feb 2023	14,027	0	-		-	Stock Option (Right to Buy)
Frank Litvack	Director	Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.31 per share.	21 Feb 2023	4,524	137,276 (2%)	0%	4.3	19,498	Common Stock
Louis V. Manzo	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.39 per share.	21 Feb 2023	1,401	62,599 (1%)	0%	1.4	1,947	Common Stock
Louis V. Manzo	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	21 Feb 2023	1,401	0	-		-	Stock Option (Right to Buy)
Louis V. Manzo	Director	Sale or transfer of securities back to the company at price $ 4.31 per share.	21 Feb 2023	452	62,147 (1%)	0%	4.3	1,948	Common Stock
Earl M. Collier	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.39 per share.	14 Feb 2023	1,401	16,856 (0%)	0%	1.4	1,947	Common Stock
Earl M. Collier	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	14 Feb 2023	1,401	0	-		-	Stock Option (Right to Buy)
George W. Dunbar	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.39 per share.	14 Feb 2023	1,401	10,556 (0%)	0%	1.4	1,947	Common Stock
George W. Dunbar	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	14 Feb 2023	1,401	0	-		-	Stock Option (Right to Buy)
David B. Musket	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2023	19,000	19,000	-		-	Stock Option (Right to Buy)
David B. Musket	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2023	37,770	37,770	-		-	Stock Option (Right to Buy)
David B. Musket	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2023	16,620	16,620	-		-	Stock Option (Right to Buy)
Earl M. Collier	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2023	37,770	37,770	-		-	Stock Option (Right to Buy)
Earl M. Collier	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2023	19,000	19,000	-		-	Stock Option (Right to Buy)
Earl M. Collier	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2023	11,870	11,870	-		-	Stock Option (Right to Buy)
Frank Litvack	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2023	185,000	185,000	-		-	Stock Option (Right to Buy)
George W. Dunbar	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2023	19,000	19,000	-		-	Stock Option (Right to Buy)
George W. Dunbar	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2023	8,310	8,310	-		-	Stock Option (Right to Buy)
George W. Dunbar	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2023	37,770	37,770	-		-	Stock Option (Right to Buy)
Linda Marban	Director, CHIEF EXECUTIVE OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2023	135,000	135,000	-		-	Stock Option (Right to Buy)
Anthony J. Bergmann	CHIEF FINANCIAL OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2023	85,000	85,000	-		-	Stock Option (Right to Buy)
Karen G. Krasney	EVP, GENERAL COUNSEL	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2023	11,878	11,878	-		-	Stock Option (Right to Buy)
Karen G. Krasney	EVP, GENERAL COUNSEL	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2023	80,000	80,000	-		-	Stock Option (Right to Buy)
Louis V. Manzo	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2023	19,000	19,000	-		-	Stock Option (Right to Buy)
Louis V. Manzo	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2023	37,770	37,770	-		-	Stock Option (Right to Buy)
Louis V. Manzo	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2023	7,120	7,120	-		-	Stock Option (Right to Buy)
Karimah Es Sabar	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2023	3,560	3,560	-		-	Stock Option (Right to Buy)
Karen G. Krasney	EVP, GENERAL COUNSEL	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	03 Nov 2022	18,932	0	-		-	Stock Option (Right to Buy)
Karen G. Krasney	EVP, GENERAL COUNSEL	Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.39 per share.	03 Nov 2022	18,932	20,047 (0%)	0%	1.4	26,315	Common Stock
Xavier Avat	CHIEF BUSINESS OFFICER	Purchase of securities on an exchange or from another person at price $ 3.68 per share.	29 Jun 2022	1,000	3,000 (0%)	0%	3.7	3,680	Common Stock
Xavier Avat	CHIEF BUSINESS OFFICER	Purchase of securities on an exchange or from another person at price $ 3.76 per share.	29 Jun 2022	1,500	2,000 (0%)	0%	3.8	5,643	Common Stock
David B. Musket	Director	Sale of securities on an exchange or to another person at price $ 4.44 per share.	27 Jun 2022	17,775	40,962 (0%)	0%	4.4	78,921	Common Stock
Xavier Avat	CHIEF BUSINESS OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 May 2022	370,000	370,000	-		-	Stock Option (Right to Buy)
Louis V. Manzo	Director	Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.43 per share.	31 Mar 2022	11,309	16,595 (0%)	0%	3.4	38,790	Common Stock
Louis V. Manzo	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2022	12,449	0	-		-	Stock Option (Right to Buy)
Louis V. Manzo	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2022	15,455	0	-		-	Stock Option (Right to Buy)
Louis V. Manzo	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.39 per share.	31 Mar 2022	27,904	27,904 (0%)	0%	1.4	38,787	Common Stock
George W. Dunbar	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.39 per share.	29 Mar 2022	15,455	15,455 (0%)	0%	1.4	21,482	Common Stock
George W. Dunbar	Director	Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.41 per share.	29 Mar 2022	6,300	9,155 (0%)	0%	3.4	21,483	Common Stock
George W. Dunbar	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	29 Mar 2022	15,455	0	-		-	Stock Option (Right to Buy)
Earl M. Collier	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.39 per share.	08 Mar 2022	15,455	15,455 (0%)	0%	1.4	21,482	Common Stock
Earl M. Collier	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	08 Mar 2022	15,455	0	-		-	Stock Option (Right to Buy)
David B. Musket	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2022	84,080	84,080	-		-	Stock Option (Right to Buy)
Earl M. Collier	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2022	63,060	63,060	-		-	Stock Option (Right to Buy)
Frank Litvack	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	03 Jan 2022	154,543	0	-		-	Stock Option (Right to Buy)
Frank Litvack	Director	Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.18 per share.	03 Jan 2022	67,552	107,382 (2%)	1%	3.2	214,815	Common Stock
Frank Litvack	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2022	252,250	252,250	-		-	Stock Option (Right to Buy)
Frank Litvack	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.39 per share.	03 Jan 2022	154,543	174,934 (3%)	3%	1.4	214,815	Common Stock
George W. Dunbar	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2022	63,060	63,060	-		-	Stock Option (Right to Buy)
Linda Marban	Director, CHIEF EXECUTIVE OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2022	377,830	377,830	-		-	Stock Option (Right to Buy)
Anthony J. Bergmann	CHIEF FINANCIAL OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2022	166,980	166,980	-		-	Stock Option (Right to Buy)
Karen G. Krasney	EVP, GENERAL COUNSEL	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2022	84,080	84,080	-		-	Stock Option (Right to Buy)
Louis V. Manzo	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2022	83,590	83,590	-		-	Stock Option (Right to Buy)
Karimah Es Sabar	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2022	7,690	7,690	-		-	Stock Option (Right to Buy)
David B. Musket	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.10 per share.	27 Dec 2021	20,391	58,737 (1%)	0%	1.1	22,430	Common Stock
David B. Musket	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	27 Dec 2021	20,391	0	-		-	Warrants (Right to Buy)
David B. Musket	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	27 Dec 2021	15,455	0	-		-	Stock Option (Right to Buy)
David B. Musket	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.39 per share.	27 Dec 2021	15,455	38,346 (0%)	0%	1.4	21,482	Common Stock
Karimah Es Sabar	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jul 2021	115,000	115,000	-		-	Stock Option (Right to Buy)
David B. Musket	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	04 Jan 2021	96,126	96,126	-		-	Stock Option (Right to Buy)
Earl M. Collier	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	04 Jan 2021	71,951	71,951	-		-	Stock Option (Right to Buy)
Frank Litvack	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	04 Jan 2021	211,160	211,160	-		-	Stock Option (Right to Buy)
George W. Dunbar	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	04 Jan 2021	71,388	71,388	-		-	Stock Option (Right to Buy)
Linda Marban	Director, CHIEF EXECUTIVE OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	04 Jan 2021	458,693	458,693	-		-	Stock Option (Right to Buy)
Anthony J. Bergmann	CHIEF FINANCIAL OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	04 Jan 2021	95,693	95,693	-		-	Stock Option (Right to Buy)
Karen G. Krasney	EVP, GENERAL COUNSEL	Grant, award, or other acquisition of securities at price $ 0.00 per share.	04 Jan 2021	95,693	95,693	-		-	Stock Option (Right to Buy)
Louis V. Manzo	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	04 Jan 2021	72,066	72,066	-		-	Stock Option (Right to Buy)
Louis Manzo	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.70 per share.	24 Sep 2020	8,299	44,603 (0%)	0%	3.7	30,706	Common Stock
Louis Manzo	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	24 Sep 2020	8,299	0	-		-	Stock Option (Right to Buy)
Linda Marban	Director, CHIEF EXECUTIVE OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.70 per share.	27 Jul 2020	41,497	62,367 (1%)	0%	3.7	153,539	Common Stock
Linda Marban	Director, CHIEF EXECUTIVE OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	27 Jul 2020	41,497	0	-		-	Stock Option (Right to Buy)
Linda Marban	Director, CHIEF EXECUTIVE OFFICER	Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.81 per share.	27 Jul 2020	15,652	46,715 (0%)	0%	9.8	153,546	Common Stock
David B. Musket	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2020	109,000	109,000	-		-	Stock Option (Right to Buy)
Earl M. Collier	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2020	83,000	83,000	-		-	Stock Option (Right to Buy)
Frank Litvack	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2020	280,935	280,935	-		-	Stock Option (Right to Buy)
George W. Dunbar	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2020	83,000	83,000	-		-	Stock Option (Right to Buy)
Linda Marban	Director, CHIEF EXECUTIVE OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2020	368,449	368,449	-		-	Stock Option (Right to Buy)
Anthony Bergmann	CHIEF FINANCIAL OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2020	120,003	120,003	-		-	Stock Option (Right to Buy)
Karen G. Krasney	EVP, GENERAL COUNSEL	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2020	104,908	104,908	-		-	Stock Option (Right to Buy)
Louis Manzo	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2020	83,000	83,000	-		-	Stock Option (Right to Buy)
David B. Musket	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Feb 2020	4,645	4,645	-		-	Stock Option (Right to Buy)
David B. Musket	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Feb 2020	4,750	4,750	-		-	Stock Option (Right to Buy)
David B. Musket	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Feb 2020	1,401	1,401	-		-	Stock Option (Right to Buy)
David B. Musket	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Feb 2020	15,455	15,455	-		-	Stock Option (Right to Buy)
David B. Musket	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	12 Feb 2020	8,750	0	-		-	Stock Option (Right to Buy)
David B. Musket	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	12 Feb 2020	3,800	0	-		-	Stock Option (Right to Buy)
David B. Musket	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Feb 2020	3,800	3,800	-		-	Stock Option (Right to Buy)
David B. Musket	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	12 Feb 2020	4,645	0	-		-	Stock Option (Right to Buy)
David B. Musket	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	12 Feb 2020	4,750	0	-		-	Stock Option (Right to Buy)
David B. Musket	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	12 Feb 2020	1,401	0	-		-	Stock Option (Right to Buy)
David B. Musket	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	12 Feb 2020	15,455	0	-		-	Stock Option (Right to Buy)
David B. Musket	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Feb 2020	8,750	8,750	-		-	Stock Option (Right to Buy)
David B. Musket	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	12 Feb 2020	3,606	0	-		-	Stock Option (Right to Buy)
David B. Musket	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Feb 2020	3,606	3,606	-		-	Stock Option (Right to Buy)
Earl M. Collier	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	12 Feb 2020	2,437	0	-		-	Stock Option (Right to Buy)
Earl M. Collier	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Feb 2020	4,750	4,750	-		-	Stock Option (Right to Buy)
Earl M. Collier	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Feb 2020	3,050	3,050	-		-	Stock Option (Right to Buy)
Earl M. Collier	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Feb 2020	2,856	2,856	-		-	Stock Option (Right to Buy)
Earl M. Collier	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Feb 2020	2,437	2,437	-		-	Stock Option (Right to Buy)
Earl M. Collier	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Feb 2020	750	750	-		-	Stock Option (Right to Buy)
Earl M. Collier	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Feb 2020	1,401	1,401	-		-	Stock Option (Right to Buy)
Earl M. Collier	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Feb 2020	15,455	15,455	-		-	Stock Option (Right to Buy)
Earl M. Collier	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	12 Feb 2020	4,750	0	-		-	Stock Option (Right to Buy)
Earl M. Collier	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	12 Feb 2020	3,050	0	-		-	Stock Option (Right to Buy)
Earl M. Collier	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	12 Feb 2020	2,856	0	-		-	Stock Option (Right to Buy)
Earl M. Collier	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	12 Feb 2020	750	0	-		-	Stock Option (Right to Buy)
Earl M. Collier	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	12 Feb 2020	1,401	0	-		-	Stock Option (Right to Buy)
Earl M. Collier	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	12 Feb 2020	15,455	0	-		-	Stock Option (Right to Buy)
Frank Litvack	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Feb 2020	3,937	3,937	-		-	Stock Option (Right to Buy)
Frank Litvack	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Feb 2020	25,000	25,000	-		-	Stock Option (Right to Buy)
Frank Litvack	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Feb 2020	20,748	20,748	-		-	Stock Option (Right to Buy)
Frank Litvack	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Feb 2020	14,027	14,027	-		-	Stock Option (Right to Buy)
Frank Litvack	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Feb 2020	154,543	154,543	-		-	Stock Option (Right to Buy)
Frank Litvack	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	12 Feb 2020	23,750	0	-		-	Stock Option (Right to Buy)
Frank Litvack	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	12 Feb 2020	6,000	0	-		-	Stock Option (Right to Buy)
Frank Litvack	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	12 Feb 2020	2,500	0	-		-	Stock Option (Right to Buy)
Frank Litvack	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	12 Feb 2020	3,937	0	-		-	Stock Option (Right to Buy)
Frank Litvack	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	12 Feb 2020	25,000	0	-		-	Stock Option (Right to Buy)
Frank Litvack	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	12 Feb 2020	20,748	0	-		-	Stock Option (Right to Buy)
Frank Litvack	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	12 Feb 2020	14,027	0	-		-	Stock Option (Right to Buy)
Frank Litvack	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	12 Feb 2020	154,543	0	-		-	Stock Option (Right to Buy)
Frank Litvack	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Feb 2020	2,500	2,500	-		-	Stock Option (Right to Buy)
Frank Litvack	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Feb 2020	6,000	6,000	-		-	Stock Option (Right to Buy)
Frank Litvack	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Feb 2020	23,750	23,750	-		-	Stock Option (Right to Buy)
George W. Dunbar	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	12 Feb 2020	15,455	0	-		-	Stock Option (Right to Buy)
George W. Dunbar	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Feb 2020	5,250	5,250	-		-	Stock Option (Right to Buy)
George W. Dunbar	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Feb 2020	2,800	2,800	-		-	Stock Option (Right to Buy)
George W. Dunbar	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Feb 2020	2,606	2,606	-		-	Stock Option (Right to Buy)
George W. Dunbar	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Feb 2020	3,000	3,000	-		-	Stock Option (Right to Buy)
George W. Dunbar	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Feb 2020	750	750	-		-	Stock Option (Right to Buy)
George W. Dunbar	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Feb 2020	1,401	1,401	-		-	Stock Option (Right to Buy)
George W. Dunbar	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Feb 2020	15,455	15,455	-		-	Stock Option (Right to Buy)
George W. Dunbar	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	12 Feb 2020	5,250	0	-		-	Stock Option (Right to Buy)
George W. Dunbar	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	12 Feb 2020	2,800	0	-		-	Stock Option (Right to Buy)
George W. Dunbar	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	12 Feb 2020	2,606	0	-		-	Stock Option (Right to Buy)
George W. Dunbar	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	12 Feb 2020	3,000	0	-		-	Stock Option (Right to Buy)
George W. Dunbar	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	12 Feb 2020	750	0	-		-	Stock Option (Right to Buy)
George W. Dunbar	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	12 Feb 2020	1,401	0	-		-	Stock Option (Right to Buy)
Linda Marban	Director, CHIEF EXECUTIVE OFFICER	Sale or transfer of securities back to the company at price $ 0.00 per share.	12 Feb 2020	41,497	0	-		-	Stock Option (Right to Buy)
Linda Marban	Director, CHIEF EXECUTIVE OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Feb 2020	41,497	41,497	-		-	Stock Option (Right to Buy)
Linda Marban	Director, CHIEF EXECUTIVE OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Feb 2020	25,000	25,000	-		-	Stock Option (Right to Buy)
Linda Marban	Director, CHIEF EXECUTIVE OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Feb 2020	19,999	19,999	-		-	Stock Option (Right to Buy)
Linda Marban	Director, CHIEF EXECUTIVE OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Feb 2020	9,998	9,998	-		-	Stock Option (Right to Buy)
Linda Marban	Director, CHIEF EXECUTIVE OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Feb 2020	25,000	25,000	-		-	Stock Option (Right to Buy)
Linda Marban	Director, CHIEF EXECUTIVE OFFICER	Sale or transfer of securities back to the company at price $ 0.00 per share.	12 Feb 2020	25,000	0	-		-	Stock Option (Right to Buy)
Linda Marban	Director, CHIEF EXECUTIVE OFFICER	Sale or transfer of securities back to the company at price $ 0.00 per share.	12 Feb 2020	9,998	0	-		-	Stock Option (Right to Buy)
Linda Marban	Director, CHIEF EXECUTIVE OFFICER	Sale or transfer of securities back to the company at price $ 0.00 per share.	12 Feb 2020	19,999	0	-		-	Stock Option (Right to Buy)
Linda Marban	Director, CHIEF EXECUTIVE OFFICER	Sale or transfer of securities back to the company at price $ 0.00 per share.	12 Feb 2020	25,000	0	-		-	Stock Option (Right to Buy)
Anthony Bergmann	CHIEF FINANCIAL OFFICER	Sale or transfer of securities back to the company at price $ 0.00 per share.	12 Feb 2020	5,000	0	-		-	Stock Option (Right to Buy)
Anthony Bergmann	CHIEF FINANCIAL OFFICER	Sale or transfer of securities back to the company at price $ 0.00 per share.	12 Feb 2020	2,500	0	-		-	Stock Option (Right to Buy)
Anthony Bergmann	CHIEF FINANCIAL OFFICER	Sale or transfer of securities back to the company at price $ 0.00 per share.	12 Feb 2020	2,178	0	-		-	Stock Option (Right to Buy)
Anthony Bergmann	CHIEF FINANCIAL OFFICER	Sale or transfer of securities back to the company at price $ 0.00 per share.	12 Feb 2020	3,000	0	-		-	Stock Option (Right to Buy)
Anthony Bergmann	CHIEF FINANCIAL OFFICER	Sale or transfer of securities back to the company at price $ 0.00 per share.	12 Feb 2020	3,500	0	-		-	Stock Option (Right to Buy)
Anthony Bergmann	CHIEF FINANCIAL OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Feb 2020	14,000	14,000	-		-	Stock Option (Right to Buy)
Anthony Bergmann	CHIEF FINANCIAL OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Feb 2020	5,000	5,000	-		-	Stock Option (Right to Buy)
Anthony Bergmann	CHIEF FINANCIAL OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Feb 2020	3,500	3,500	-		-	Stock Option (Right to Buy)
Anthony Bergmann	CHIEF FINANCIAL OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Feb 2020	3,000	3,000	-		-	Stock Option (Right to Buy)
Anthony Bergmann	CHIEF FINANCIAL OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Feb 2020	2,500	2,500	-		-	Stock Option (Right to Buy)
Anthony Bergmann	CHIEF FINANCIAL OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Feb 2020	2,178	2,178	-		-	Stock Option (Right to Buy)
Anthony Bergmann	CHIEF FINANCIAL OFFICER	Sale or transfer of securities back to the company at price $ 0.00 per share.	12 Feb 2020	14,000	0	-		-	Stock Option (Right to Buy)
Karen G. Krasney	EVP, GENERAL COUNSEL	Sale or transfer of securities back to the company at price $ 0.00 per share.	12 Feb 2020	3,000	0	-		-	Stock Option (Right to Buy)
Karen G. Krasney	EVP, GENERAL COUNSEL	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Feb 2020	3,500	3,500	-		-	Stock Option (Right to Buy)
Karen G. Krasney	EVP, GENERAL COUNSEL	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Feb 2020	14,000	14,000	-		-	Stock Option (Right to Buy)
Karen G. Krasney	EVP, GENERAL COUNSEL	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Feb 2020	5,000	5,000	-		-	Stock Option (Right to Buy)
Karen G. Krasney	EVP, GENERAL COUNSEL	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Feb 2020	2,500	2,500	-		-	Stock Option (Right to Buy)
Karen G. Krasney	EVP, GENERAL COUNSEL	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Feb 2020	3,000	3,000	-		-	Stock Option (Right to Buy)
Karen G. Krasney	EVP, GENERAL COUNSEL	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Feb 2020	18,932	18,932	-		-	Stock Option (Right to Buy)
Karen G. Krasney	EVP, GENERAL COUNSEL	Sale or transfer of securities back to the company at price $ 0.00 per share.	12 Feb 2020	14,000	0	-		-	Stock Option (Right to Buy)
Karen G. Krasney	EVP, GENERAL COUNSEL	Sale or transfer of securities back to the company at price $ 0.00 per share.	12 Feb 2020	3,500	0	-		-	Stock Option (Right to Buy)
Karen G. Krasney	EVP, GENERAL COUNSEL	Sale or transfer of securities back to the company at price $ 0.00 per share.	12 Feb 2020	2,500	0	-		-	Stock Option (Right to Buy)
Karen G. Krasney	EVP, GENERAL COUNSEL	Sale or transfer of securities back to the company at price $ 0.00 per share.	12 Feb 2020	5,000	0	-		-	Stock Option (Right to Buy)
Karen G. Krasney	EVP, GENERAL COUNSEL	Sale or transfer of securities back to the company at price $ 0.00 per share.	12 Feb 2020	18,932	0	-		-	Stock Option (Right to Buy)
Louis Manzo	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Feb 2020	2,550	2,550	-		-	Stock Option (Right to Buy)
Louis Manzo	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Feb 2020	1,401	1,401	-		-	Stock Option (Right to Buy)
Louis Manzo	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Feb 2020	4,500	4,500	-		-	Stock Option (Right to Buy)
Louis Manzo	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Feb 2020	1,500	1,500	-		-	Stock Option (Right to Buy)
Louis Manzo	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Feb 2020	3,000	3,000	-		-	Stock Option (Right to Buy)
Louis Manzo	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	12 Feb 2020	27,904	0	-		-	Stock Option (Right to Buy)
Louis Manzo	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	12 Feb 2020	1,401	0	-		-	Stock Option (Right to Buy)
Louis Manzo	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	12 Feb 2020	1,500	0	-		-	Stock Option (Right to Buy)
Louis Manzo	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	12 Feb 2020	3,000	0	-		-	Stock Option (Right to Buy)
Louis Manzo	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	12 Feb 2020	2,356	0	-		-	Stock Option (Right to Buy)
Louis Manzo	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	12 Feb 2020	2,550	0	-		-	Stock Option (Right to Buy)
Louis Manzo	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	12 Feb 2020	4,500	0	-		-	Stock Option (Right to Buy)
Louis Manzo	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Feb 2020	27,904	27,904	-		-	Stock Option (Right to Buy)
Louis Manzo	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Feb 2020	2,356	2,356	-		-	Stock Option (Right to Buy)
David B. Musket	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Dec 2019	20,391	22,891 (0%)	0%		0	Common Stock
David B. Musket	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Dec 2019	20,391	20,391	-		-	Warrants (Right to Buy)
Frank Litvack	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Dec 2019	20,391	20,391	-		-	Warrants (Right to Buy)
Frank Litvack	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Dec 2019	20,391	20,391 (0%)	0%		0	Common Stock
Louis Manzo	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Dec 2019	20,391	36,304 (0%)	0%		0	Common Stock
Louis Manzo	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Dec 2019	20,391	20,391	-		-	Warrants (Right to Buy)
David B. Musket	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Aug 2019	8,750	8,750	-		-	Stock Option (right to buy)
Earl M. Collier	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Aug 2019	4,750	4,750	-		-	Stock Option (right to buy)
Frank Litvack	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Aug 2019	23,750	23,750	-		-	Stock Option (right to buy)
George W. Dunbar	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Aug 2019	5,250	5,250	-		-	Stock Option (right to buy)
Linda Marban	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Aug 2019	25,000	25,000	-		-	Stock Option (right to buy)
Anthony Bergmann	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Aug 2019	14,000	14,000	-		-	Stock Option (right to buy)
Karen G. Krasney	EVP, General Counsel	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Aug 2019	14,000	14,000	-		-	Stock Option (right to buy)
Louis Manzo	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Aug 2019	4,500	4,500	-		-	Stock Option (right to buy)
Deborah Ascheim	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jul 2018	50,000	50,000	-		-	Stock Option (right to buy)
David B. Musket	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2018	38,000	38,000	-		-	Stock Option (right to buy)
Earl M. Collier	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2018	30,500	30,500	-		-	Stock Option (right to buy)
Frank Litvack	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2018	60,000	60,000	-		-	Stock Option (right to buy)
George W. Dunbar	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2018	28,000	28,000	-		-	Stock Option (right to buy)
Joshua A. Kazam	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2018	18,000	18,000	-		-	Stock Option (right to buy)
Linda Marban	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2018	100,000	100,000	-		-	Stock Option (right to buy)
Anthony Bergmann	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2018	50,000	50,000	-		-	Stock Option (right to buy)
Karen G. Krasney	EVP, General Counsel	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2018	35,000	35,000	-		-	Stock Option (right to buy)
Rachel Smith	Vice President of R&D	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2018	50,000	50,000	-		-	Stock Option (right to buy)
Louis Manzo	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2018	25,500	25,500	-		-	Stock Option (right to buy)
Deborah Ascheim	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2018	43,122	43,122	-		-	Stock Option (right to buy)
Joshua A. Kazam	None	Gift of securities by or to the insider at price $ 0.00 per share.	31 Dec 2017	1,000	37,084 (0%)	0%		0	Common Stock
Joshua A. Kazam	None	Gift of securities by or to the insider at price $ 0.00 per share.	31 Dec 2017	17,786	19,298 (0%)	0%		0	Common Stock
Rachel Smith	Vice President of R&D	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	22 Dec 2017	20,748	0	-		-	Stock Option (right to buy)
Rachel Smith	Vice President of R&D	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.16 per share.	22 Dec 2017	20,748	20,748 (0%)	0%	0.2	3,320	Common Stock
Rachel Smith	Vice President of R&D	Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.48 per share.	22 Dec 2017	2,244	18,504 (0%)	0%	1.5	3,321	Common Stock
Louis Manzo	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.16 per share.	23 Oct 2017	20,748	159,132 (0%)	0%	0.2	3,320	Common Stock
Louis Manzo	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Oct 2017	20,748	0	-		-	Stock Option (right to buy)
David B. Musket	None	Purchase of securities on an exchange or from another person at price $ 3.10 per share.	09 May 2017	25,000	25,000 (0%)	0%	3.1	77,500	Common Stock
Louis Manzo	None	Purchase of securities on an exchange or from another person at price $ 3.10 per share.	09 May 2017	10,000	138,384 (0%)	0%	3.1	31,000	Common Stock
David B. Musket	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2017	36,060	36,060	-		-	Stock Option (right to buy)
Earl M. Collier	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2017	28,560	28,560	-		-	Stock Option (right to buy)
Frank Litvack	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2017	25,000	25,000	-		-	Stock Option (right to buy)
George W. Dunbar	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2017	26,060	26,060	-		-	Stock Option (right to buy)
Joshua A. Kazam	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2017	16,060	16,060	-		-	Stock Option (right to buy)
Linda Marban	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2017	200,000	200,000	-		-	Stock Option (right to buy)
Anthony Bergmann	Vice President of Finance	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2017	35,000	35,000	-		-	Stock Option (right to buy)
Karen G. Krasney	See Remarks	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2017	25,000	25,000	-		-	Stock Option (right to buy)
Rachel Smith	Vice President of R&D	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2017	35,000	35,000	-		-	Stock Option (right to buy)
Louis Manzo	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2017	23,560	23,560	-		-	Stock Option (right to buy)
Deborah Ascheim	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2017	50,000	50,000	-		-	Stock Option (right to buy)
Linda Marban	Director, Chief Executive Officer	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	31 Dec 2016	5,076	5,076	-		-	Warrants (Right to Buy)
Linda Marban	Director, Chief Executive Officer	Gift of securities by or to the insider at price $ 0.00 per share.	31 Dec 2016	65,000	208,709	-		-	Common Stock
Linda Marban	Director, Chief Executive Officer	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	31 Dec 2016	10,152	208,709	-		-	Common Stock
Earl M. Collier	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jun 2016	24,375	24,375	-		-	Stock Option (right to buy)
George W. Dunbar	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jun 2016	30,000	30,000	-		-	Stock Option (right to buy)
David B. Musket	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jun 2016	46,458	46,458	-		-	Stock Option (right to buy)
Joshua A. Kazam	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jun 2016	15,000	15,000	-		-	Stock Option (right to buy)
Frank Litvack	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jun 2016	39,375	39,375	-		-	Stock Option (right to buy)
Anthony Bergmann	Vice President of Finance	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jun 2016	30,000	30,000	-		-	Stock Option (right to buy)
Karen G. Krasney	See Remarks	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jun 2016	50,000	50,000	-		-	Stock Option (right to buy)
Rachel Smith	Vice President of R&D	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jun 2016	50,000	50,000	-		-	Stock Option (right to buy)
Louis Manzo	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jun 2016	30,000	30,000	-		-	Stock Option (right to buy)
Leland Gershell	CHIEF FINANCIAL OFFICER	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	16 Mar 2016	1,050	1,050	-		-	Warrants (Right to Buy)
Leland Gershell	CHIEF FINANCIAL OFFICER	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	16 Mar 2016	2,100	2,100	-		-	Common Stock
Linda Marban	Director, Chief Executive Officer	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	16 Mar 2016	5,076	5,076	-		-	Warrants (Right to Buy)
Linda Marban	Director, Chief Executive Officer	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	16 Mar 2016	10,152	273,709	-		-	Common Stock
Anthony Bergmann	Vice President of Finance	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	16 Mar 2016	1,015	1,015	-		-	Warrants (Right to Buy)
Anthony Bergmann	Vice President of Finance	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	16 Mar 2016	2,030	2,030	-		-	Common Stock
Louis Manzo	None	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	16 Mar 2016	50,000	50,000	-		-	Warrants (Right to Buy)
Louis Manzo	None	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	16 Mar 2016	100,000	128,384	-		-	Common Stock
Louis J. Grasmick	None	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	16 Mar 2016	35,532	35,532	-		-	Warrants (Right to Buy)
Louis J. Grasmick	None	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	16 Mar 2016	10,152	10,152	-		-	Warrants (Right to Buy)
Louis J. Grasmick	None	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	16 Mar 2016	71,065	77,015	-		-	Common Stock
Louis J. Grasmick	None	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	16 Mar 2016	20,304	1,059,740	-		-	Common Stock
Leland Gershell	CHIEF FINANCIAL OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Mar 2016	166,500	166,500	-		-	Stock Option (right to buy)
Linda Marban	Director, CEO	Gift of securities by or to the insider at price $ 0.00 per share.	31 Dec 2015	5,000	263,557	-		-	Common Stock
Deborah Ascheim	CHIEF MEDICAL OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	18 Sep 2015	130,000	130,000	-		-	Stock Option (right to buy)
Louis J. Grasmick	None	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	19 Aug 2015	4,630	5,950	-		-	Common Stock
Louis J. Grasmick	None	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	19 Aug 2015	1,320	1,320	-		-	Common Stock
Louis J. Grasmick	None	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	19 Aug 2015	4,630	5,950	-		-	Common Stock
Louis J. Grasmick	None	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	19 Aug 2015	1,320	1,320	-		-	Common Stock
Linda Marban	Director, Chief Executive Officer	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	18 Aug 2015	4,200	3,173,354	-		-	Common Stock
Linda Marban	Director, Chief Executive Officer	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	18 Aug 2015	5,000	264,357	-		-	Common Stock
Linda Marban	Director, Chief Executive Officer	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	18 Aug 2015	4,200	268,557	-		-	Common Stock
Linda Marban	Director, Chief Executive Officer	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	18 Aug 2015	5,000	3,169,154	-		-	Common Stock
Gregory W. Schafer	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 May 2011	100,000	100,000	-		-	Stock Option (Right to Buy)
Pedro P. Granadillo	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 May 2011	100,000	100,000	-		-	Stock Option (Right to Buy)
Peter Morgan Kash	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 May 2011	80,000	80,000	-		-	Stock Option (Right to Buy)
Arie S. Belldegrun	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 May 2011	80,000	80,000	-		-	Stock Option (Right to Buy)
Paul A. Mieyal	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 May 2011	80,000	80,000	-		-	Stock Option (Right to Buy)
Joshua A. Kazam	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 May 2011	80,000	80,000	-		-	Stock Option (Right to Buy)
Frank Litvack	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 May 2011	80,000	80,000	-		-	Stock Option (Right to Buy)
Daron Evans	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	18 Apr 2011	50,000	50,000	-		-	Stock Option (Right to Buy)
Daron Evans	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2011	18,128	85,628	-		-	Stock Option (Right to Buy)
Hsiao Dee Lieu	VP, Clinical Research	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2011	27,192	128,442	-		-	Stock Option (Right to Buy)
Hsiao Dee Lieu	VP, Clinical Research	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Dec 2010	25,000	46,623	-		-	Stock Option (Right to Buy)
Gregory W. Schafer	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Jul 2010	100,000	100,000	-		-	Stock Option (Right to Buy)
Pedro P. Granadillo	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Jul 2010	100,000	100,000	-		-	Stock Option (Right to Buy)
Peter Morgan Kash	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Jul 2010	80,000	80,000	-		-	Stock Option (Right to Buy)
Richard B. Brewer	Director, Executive Chairman	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Jul 2010	900,000	900,000	-		-	Stock Option (Right to Buy)
Arie S. Belldegrun	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Jul 2010	80,000	80,000	-		-	Stock Option (Right to Buy)
Paul A. Mieyal	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Jul 2010	80,000	80,000	-		-	Stock Option (Right to Buy)
Joshua A. Kazam	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Jul 2010	80,000	80,000	-		-	Stock Option (Right to Buy)
Daron Evans	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Jul 2010	250,000	250,000	-		-	Stock Option (Right to Buy)
Frank Litvack	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Jul 2010	80,000	80,000	-		-	Stock Option (Right to Buy)
Richard B. Brewer	Director, Executive Chairman	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jul 2010	450,000	450,000	-		-	Stock Option (Right to Buy)
Daron Evans	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Jul 2010	200,000	200,000	-		-	Stock Option (Right to Buy)
Hsiao Dee Lieu	VP, Clinical Research	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Jul 2010	100,000	100,000	-		-	Stock Option (Right to Buy)
Joshua A. Kazam	Director, Chief Executive Officer	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	22 Apr 2010	15,000	15,000	-		-	Warrant (Right to Buy)
Joshua A. Kazam	Director, Chief Executive Officer	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	22 Apr 2010	50,000	1,328,228	-		-	Common Stock
Daron Evans	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Feb 2010	42,500	67,500	-		-	Stock Option (Right to Buy)
Hsiao Dee Lieu	VP, Clinical Research	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Feb 2010	63,750	101,250	-		-	Stock Option (Right to Buy)
Daron Evans	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	19 Jan 2010	50,000	169,797	-		-	Stock Option (Right to Buy)
Hsiao Dee Lieu	VP, Clinical Research	Grant, award, or other acquisition of securities at price $ 0.00 per share.	19 Jan 2010	12,500	21,623	-		-	Stock Option (Right to Buy)
David M. Tanen	None		31 Dec 2009	50,000	0	-		-	Stock Option (Right to Buy)
David M. Tanen	None		31 Dec 2009	50,000	50,000	-		-	Stock Option (Right to Buy)
David M. Tanen	None		31 Dec 2009	25,000	0	-		-	Stock Option (Right to Buy)
David M. Tanen	None		31 Dec 2009	25,000	25,000	-		-	Stock Option (Right to Buy)
David M. Tanen	None		31 Dec 2009	65,000	0	-		-	Stock Option (Right to Buy)
David M. Tanen	None		31 Dec 2009	65,000	65,000	-		-	Stock Option (Right to Buy)
Arie S. Belldegrun	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Sep 2009	130,000	130,000	-		-	Stock Option (Right to Buy)
Frank Litvack	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Sep 2009	130,000	130,000	-		-	Stock Option (Right to Buy)
Gregory W. Schafer	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jul 2009	80,000	80,000	-		-	Stock Option (Right to Buy)
David M. Tanen	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jul 2009	65,000	65,000	-		-	Stock Option (Right to Buy)
Pedro P. Granadillo	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jul 2009	80,000	80,000	-		-	Stock Option (Right to Buy)
Peter Morgan Kash	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jul 2009	80,000	80,000	-		-	Stock Option (Right to Buy)
Paul A. Mieyal	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jul 2009	65,000	65,000	-		-	Stock Option (Right to Buy)
Joshua A. Kazam	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jul 2009	65,000	65,000	-		-	Stock Option (Right to Buy)
David M. Tanen	None	Other type of transaction at price $ 0.00 per share.	15 Jul 2009	31,650	31,650	-		-	Warrant (Right to Buy)
Peter Morgan Kash	None	Other type of transaction at price $ 0.00 per share.	15 Jul 2009	125,000	125,000	-		-	Warrant (Right to Buy)
Joshua A. Kazam	None	Other type of transaction at price $ 0.00 per share.	14 Jul 2009	31,650	31,650	-		-	Warrant (Right to Buy)
Peter Morgan Kash	None	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	07 Jul 2009	24,704	24,704	-		-	Warrant (Right to Buy)
Peter Morgan Kash	None	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	07 Jul 2009	24,703	24,703	-		-	Warrant (Right to Buy)
Peter Morgan Kash	None	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	07 Jul 2009	49,407	49,407	-		-	Warrant (Right to Buy)
Peter Morgan Kash	None	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	07 Jul 2009	98,814	1,596,208	-		-	Common Stock
Joshua A. Kazam	None	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	07 Jul 2009	197,628	1,278,228	-		-	Common Stock
Joshua A. Kazam	None	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	07 Jul 2009	49,407	49,407	-		-	Warrant (Right to Buy)
Joshua A. Kazam	None	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	07 Jul 2009	49,407	49,407	-		-	Warrant (Right to Buy)
Joshua A. Kazam	None	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	07 Jul 2009	98,814	98,814	-		-	Warrant (Right to Buy)
Daron Evans	Chief Financial Officer	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	07 Jul 2009	988	988	-		-	Warrant (Right to Buy)
Daron Evans	Chief Financial Officer	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	07 Jul 2009	988	988	-		-	Warrant (Right to Buy)
Daron Evans	Chief Financial Officer	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	07 Jul 2009	1,976	1,976	-		-	Warrant (Right to Buy)
Daron Evans	Chief Financial Officer	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	07 Jul 2009	3,952	14,152	-		-	Common Stock
Daron Evans	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jun 2009	25,000	25,000	-		-	Stock Option (Right to Buy)
Joshua A. Kazam	None	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	12 Mar 2009	510	1,080,600	-		-	Common Stock
Daron Evans	Chief Financial Officer	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	11 Mar 2009	6,000	10,200	-		-	Common Stock
Daron Evans	Chief Financial Officer	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	11 Mar 2009	5,000	9,200	-		-	Common Stock
Peter M. Strumph	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Jan 2009	149,148	149,148	-		-	Employee Stock Option (right to buy)
Daron Evans	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Jan 2009	49,020	49,020	-		-	Stock Option (Right to Buy)
Daron Evans	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Jan 2009	43,269	43,269	-		-	Stock Option (Right to Buy)
Gregory W. Schafer	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Dec 2008	35,000	35,000	-		-	Non-Qualified Stock Option (right to buy)
David M. Tanen	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Dec 2008	25,000	25,000	-		-	Non-Qualified Stock Option (right to buy)
Pedro P. Granadillo	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Dec 2008	35,000	35,000	-		-	Non-Qualified Stock Option (right to buy)
Peter Morgan Kash	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Dec 2008	35,000	35,000	-		-	Non-Qualified Stock Option (right to buy)
Paul A. Mieyal	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Dec 2008	25,000	25,000	-		-	Non-Qualified Stock Option (right to buy)
Joshua A. Kazam	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Dec 2008	25,000	25,000	-		-	Non-Qualified Stock Option (right to buy)
David M. Tanen	None	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	16 Dec 2008	2,500	1,520,705	-		-	Common Stock
Joshua A. Kazam	None	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	16 Dec 2008	3,100	1,080,090	-		-	Common Stock
Joshua A. Kazam	None	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	15 Dec 2008	2,500	1,076,990	-		-	Common Stock
David M. Tanen	None	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	12 Dec 2008	4,000	1,515,705	-		-	Common Stock
David M. Tanen	None	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	12 Dec 2008	20	1,515,725	-		-	Common Stock
David M. Tanen	None	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	12 Dec 2008	2,480	1,518,205	-		-	Common Stock
Peter M. Strumph	Director, Chief Executive Officer	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	12 Dec 2008	1,000	5,580	-		-	Common Stock
Peter M. Strumph	Director, Chief Executive Officer	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	12 Dec 2008	2,000	7,580	-		-	Common Stock
Daron Evans	Chief Financial Officer	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	12 Dec 2008	1,000	4,200	-		-	Common Stock
Daron Evans	Chief Financial Officer	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	12 Dec 2008	3,186	4,200	-		-	Common Stock
David M. Tanen	None	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	11 Dec 2008	4,000	1,511,705	-		-	Common Stock
Peter Morgan Kash	None	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	11 Dec 2008	600	1,492,344	-		-	Common Stock
Peter Morgan Kash	None	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	11 Dec 2008	1,500	1,493,844	-		-	Common Stock
Peter Morgan Kash	None	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	11 Dec 2008	2,500	1,496,344	-		-	Common Stock
Joshua A. Kazam	None	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	11 Dec 2008	4,100	1,070,390	-		-	Common Stock
Joshua A. Kazam	None	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	11 Dec 2008	4,100	1,074,490	-		-	Common Stock
Peter M. Strumph	Director, Chief Executive Officer	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	11 Dec 2008	3,580	4,580	-		-	Common Stock
Daron Evans	Chief Financial Officer	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	11 Dec 2008	3,000	3,200	-		-	Common Stock
Daron Evans	Chief Financial Officer	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	11 Dec 2008	814	1,014	-		-	Common Stock
Gregory W. Schafer	None	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	15 Apr 2008	100	100	-		-	Common Stock
Peter M. Strumph	Director, Chief Executive Officer	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	14 Apr 2008	1,000	1,000	-		-	Common Stock
Peter M. Strumph	Director, Chief Executive Officer	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	14 Apr 2008	200	200	-		-	Common Stock
Peter M. Strumph	Director, Chief Executive Officer	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	14 Apr 2008	200	200	-		-	Common Stock
Daron Evans	Chief Financial Officer	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	14 Apr 2008	200	200	-		-	Common Stock
Daron Evans	Chief Financial Officer	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	14 Apr 2008	200	200	-		-	Common Stock
Daron Evans	Chief Financial Officer	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	14 Apr 2008	200	200	-		-	Common Stock
Daron Evans	Chief Financial Officer	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	14 Apr 2008	200	200	-		-	Common Stock
Hsiao Dee Lieu	VP, Clinical Research	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	10 Mar 2008	100	100	-		-	Common Stock
Hsiao Dee Lieu	VP, Clinical Research	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Mar 2008	200,000	200,000	-		-	Stock Option (Right to Buy)
Hsiao Dee Lieu	VP, Clinical Research	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Mar 2008	9,123	9,123	-		-	Stock Option (Right to Buy)
Hsiao Dee Lieu	VP, Clinical Research	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Mar 2008	31,003	31,003	-		-	Stock Option (Right to Buy)
Hsiao Dee Lieu	VP, Clinical Research	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Mar 2008	37,500	37,500	-		-	Stock Option (Right to Buy)
Peter M. Strumph	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	04 Mar 2008	139,008	139,008	-		-	Employee Stock Option (right to buy)
Daron Evans	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	04 Mar 2008	76,528	76,528	-		-	Employee Stock Option (right to buy)
Gregory W. Schafer	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	25 Jan 2008	60,000	60,000	-		-	Non-Qualified Stock Option (right to buy)
David M. Tanen	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	25 Jan 2008	50,000	50,000	-		-	Non-Qualified Stock Option (right to buy)
Pedro P. Granadillo	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	25 Jan 2008	60,000	60,000	-		-	Non-Qualified Stock Option (right to buy)
Peter Morgan Kash	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	25 Jan 2008	60,000	60,000	-		-	Non-Qualified Stock Option (right to buy)
Paul A. Mieyal	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	25 Jan 2008	50,000	50,000	-		-	Non-Qualified Stock Option (right to buy)
Joshua A. Kazam	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	25 Jan 2008	50,000	50,000	-		-	Non-Qualified Stock Option (right to buy)

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades disclosures

45.04% Fall from 52W High

Insider Trading disclosures for Capricor Therapeutics Inc

The latest disclosure was made by Linda Marban in Capricor Therapeutics Inc where a trade of 25,000 Stock Option (Right to Buy) done was reported to US exchanges on March 3, 2025.

Screeners based on Insider Trading and SAST parameters